ORCHESTRATING THE IMMUNE SYSTEM
LIVE

Serial Number

97518230

Owner

Mozart Therapeutics, Inc.

Attorney

Connie Ellerbach

Filing Date

Jul 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ORCHESTRATING THE IMMUNE SYSTEM Trademark

Serial Number: 97518230

ORCHESTRATING THE IMMUNE SYSTEM is a trademark filed by Mozart Therapeutics, Inc. on July 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Mozart Therapeutics, Inc. (2 trademarks)

410 W Harrison Street, Suite 150
Seattle, WA 98119

Entity Type: 03

Trademark Details

Filing Date

July 25, 2022

Registration Date

Not Registered

Published for Opposition

September 5, 2023

Goods & Services

Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; pharmaceutical products and preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; biological products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic and medicinal products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, and cancer; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders

Filing History

CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 16, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Mar 9, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 9, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 9, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 5, 2025 EXRA
SOU EXTENSION 3 GRANTED
Apr 5, 2025 EX3G
SOU EXTENSION 3 FILED
Apr 4, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 23, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 23, 2024 EX2G
SOU EXTENSION 2 FILED
Oct 23, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 23, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 5, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 31, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2023 CNRT
ASSIGNED TO EXAMINER
May 10, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2022 NWOS
NEW APPLICATION ENTERED
Jul 28, 2022 NWAP